Dynamically Coupled Residues within the SH2 Domain of FYN Are Key to Unlocking Its Activity.
Src kinase activity is controlled by various mechanisms involving a coordinated movement of kinase and regulatory domains. Notwithstanding the extensive knowledge related to the backbone dynamics, little is known about the more subtle side-chain dynamics within the regulatory domains and their role in the activation process. Here, we show through experimental methyl dynamic results and predicted changes in side-chain conformational couplings that the SH2 structure of Fyn contains a dynamic network capable of propagating binding information. We reveal that binding the phosphorylated tail of Fyn perturbs a residue cluster near the linker connecting the SH2 and SH3 domains of Fyn, which is known to be relevant in the regulation of the activity of Fyn. Biochemical perturbation experiments validate that those residues are essential for inhibition of Fyn, leading to a gain of function upon mutation. These findings reveal how side-chain dynamics may facilitate the allosteric regulation of the different members of the Src kinase family.
Structural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussel, Belgium; Structural Biology Research Center, VIB, Pleinlaan 2, 1050 Brussel, Belgium.
Radu
R
Huculeci
MLG, Départment d'Informatique, Université Libre de Bruxelles, Boulevard du Triomphe CP212, 1050 Brussels, Belgium; Interuniversity Institute of Bioinformatics Brussels (IB(2)), ULB-VUB, La Plaine Campus, Boulevard du Triomphe CP 263, 1050 Brussels, Belgium.
Elisa
E
Cilia
Department of Pharmacological Sciences, Stony Brook University School of Medicine, BST 8-140, Stony Brook, NY 11794-8651, USA.
Agatha
A
Lyczek
Structural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussel, Belgium; Structural Biology Research Center, VIB, Pleinlaan 2, 1050 Brussel, Belgium.
Lieven
L
Buts
NMR spectroscopy, Bijvoet Center for Biomolecular Research, Utrecht University, Padualaan 8, 3584 CH Utrecht, the Netherlands.
Klaartje
K
Houben
Department of Pharmacological Sciences, Stony Brook University School of Medicine, BST 8-140, Stony Brook, NY 11794-8651, USA.
Markus A
MA
Seeliger
Structural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussel, Belgium; Structural Biology Research Center, VIB, Pleinlaan 2, 1050 Brussel, Belgium. Electronic address: nico.van.nuland@vub.ac.be.
Nico
N
van Nuland
MLG, Départment d'Informatique, Université Libre de Bruxelles, Boulevard du Triomphe CP212, 1050 Brussels, Belgium; Interuniversity Institute of Bioinformatics Brussels (IB(2)), ULB-VUB, La Plaine Campus, Boulevard du Triomphe CP 263, 1050 Brussels, Belgium; AI-lab, Vakgroep Computerwetenschappen, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium. Electronic address: tom.lenaerts@ulb.ac.be.
Tom
T
Lenaerts
D020816:Amino Acid Motifs; D005786:Gene Expression Regulation; D006801:Humans; D008958:Models, Molecular; D019906:Nuclear Magnetic Resonance, Biomolecular; D010766:Phosphorylation; D051076:Proto-Oncogene Proteins c-fyn / Q000737:chemistry* / Q000378:metabolism*; D018909:src Homology Domains
C494957:FYN protein, human; D051076:Proto-Oncogene Proteins c-fyn
Fyn; SH2; Src-like kinases; long-range communication; methyl dynamics; prediction; regulation
Nucleic Acids Res. 2009 Jan;37(Database issue):D824-31
18986996
J Am Chem Soc. 2002 Jun 5;124(22):6449-60
12033876
Sci Signal. 2010 May 04;3(120):ra34
20442417
Alzheimers Res Ther. 2014 Feb 05;6(1):8
24495408
Structure. 2005 Jun;13(6):861-71
15939018
BMC Struct Biol. 2008 Oct 08;8:43
18842137
Biochemistry. 1994 May 17;33(19):5984-6003
7514039
Protein Sci. 2005 Dec;14(12):3135-9
16260764
Biochemistry. 1998 Jun 23;37(25):9083-90
9636054
Oncogene. 2004 Oct 18;23(48):7918-27
15489910
J Comput Biol. 1999 Fall-Winter;6(3-4):281-97
10582567
J Mol Biol. 2004 Jan 23;335(4):1105-15
14698303
J Biomol NMR. 1995 Nov;6(3):277-93
8520220
PLoS Comput Biol. 2016 May 23;12(5):e1004938
27213566
PLoS One. 2009 Jul 23;4(7):e6361
19626122
Cell. 2008 Jul 11;134(1):124-34
18614016
BJU Int. 2009 Jan;103(2):171-7
18990162
Biochemistry. 1998 May 19;37(20):7119-26
9585523
Science. 2002 Dec 6;298(5600):1912-34
12471243
J Neurosci. 2004 Mar 3;24(9):2304-12
14999081
Protein Sci. 2006 Jan;15(1):65-73
16322569
Science. 1985 Jul 5;229(4708):23-8
3892686
Biochemistry. 1997 Nov 25;36(47):14561-71
9398174
Curr Protein Pept Sci. 2009 Apr;10(2):116-27
19355979
J Mol Biol. 2008 Apr 18;378(1):1-11
18353365
Int J Cancer. 2009 May 1;124(9):2124-34
19142869
J Mol Biol. 1998 Feb 20;276(2):461-78
9512716
Biophys J. 2007 Oct 15;93(8):2830-44
17586564
EMBO J. 1993 Jul;12(7):2625-34
7687537
Int J Cancer. 2008 Aug 15;123(4):801-9
18506685
Eur Biophys J. 1996;24(6):371-80
8765711
Carcinogenesis. 2011 Oct;32(10):1419-26
21642356
Biochemistry. 1996 Jan 16;35(2):361-8
8555205
J Am Chem Soc. 2002 Jun 5;124(22):6439-48
12033875
Mol Cell. 2006 Mar 17;21(6):787-98
16543148
Oncogene. 2004 Oct 18;23(48):7906-9
15489908
Nat Struct Biol. 1998 Feb;5(2):156-63
9461082
Cell Mol Life Sci. 2008 Oct;65(19):3058-73
18563293
J Biomol NMR. 2000 Jan;16(1):23-8
10718609
J Mol Biol. 1999 Apr 2;287(3):645-56
10092465
PLoS One. 2012;7(12):e51611
23284724
J Biomol NMR. 1999 Feb;13(2):181-5
20700817
PLoS Comput Biol. 2012;8(11):e1002794
23209399
Cell. 2001 Apr 6;105(1):115-26
11301007
Proteins. 2008 Apr;71(1):455-66
17957766
Nat Struct Biol. 2000 Jan;7(1):72-7
10625431
J Alzheimers Dis. 2011;27(2):243-52
21799250
Nature. 1997 Feb 13;385(6617):650-3
9024665
Chem Rev. 2006 May;106(5):1672-99
16683749
Proteins. 2008 Aug;72(2):779-92
18260110
Structure. 2007 Mar;15(3):299-311
17355866
J Biol Chem. 2001 May 18;276(20):17199-205
11278857
Structure. 2002 Jul;10(7):901-11
12121645
J Mol Biol. 2002 Sep 20;322(3):605-20
12225753
Biochemistry. 1995 Nov 14;34(45):14843-51
7578094